Paltimatrectinib
Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA) .Paltimatrectinib is used in the study of bladder, breast and colorectal cancers.
Product Specifications
CAS Number
2353522-15-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
434.37
Molecular Formula
C20H15F5N6
Notes
Research use only, not for human use.
Receptor
Tyrosine Kinases | Trk receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog